Sia J, Whittle JR. Residual Disease as a Decider. International Journal of Radiation Oncology • Biology • Physics. 2025;122(2):10.1016/j.ijrobp.2024.12.051
Kalla M, Bradford A, Schadewaldt V, Burns K, Bray SCE, Cain S, McAlpine H, Dhillon RS, Chapman W, Whittle JR, J Drummond K, Krishnasamy M. Co-Designing a User-Centered Digital Health Tool for Supportive Care Needs of Patients With Brain Tumors and Their Caregivers: Interview Analysis.JMIR Cancer. 2025;11:10.2196/53690
O’Keeffe P, Nouri Y, Saw HS, Moore Z, Baldwin TM, Olechnowicz SWZ, Jabbari JS, Squire DM, Leslie S, Wang C, You Y, Ritchie ME, Cross RS, Jenkins MR, Audiger C, Naik SH, Whittle JR, Freytag S, Best SA, Hickey PF, Amann-Zalcenstein D, Bowden R, Brown DV. TIRE-seq simplifies transcriptomics via integrated RNA capture and library preparation. Scientific Reports. 2025;15(1):10.1038/s41598-025-98282-8
Kalla M, Huckvale K, Bradford A, Schadewaldt V, Bray SCE, Borda A, Burns K, McAlpine H, Thomas J, Capurro D, De Abreu Lourenco R, Cain S, Chapman W, Whittle JR, Drummond KJ, Krishnasamy M. To framework, or not to framework? Reflections from co-design of a digital supportive care platform for patients with brain tumours and their carers. Digital Health. 2025;11:10.1177/20552076251339302
Whittle JR, Kriel J, Fatunla OE, Lu T, Moffet JJD, Spiteri M, Best SA, Freytag S. Spatial omics shed light on the tumour organisation of glioblastoma. Seminars in Cell and Developmental Biology. 2025;167:10.1016/j.semcdb.2024.12.006
Kay KE, Lee J, Hong ES, Beilis J, Dayal S, Wesley ER, Mitchell S, Wang SZ, Silver DJ, Volovetz J, Johnson S, McGraw M, Grabowski M, Lu T, Freytag L, Narayana VK, Freytag S, Best SA, Whittle JR, Wang Z, Reizes O, Yu JS, Hazen SL, Brown JM, Bayik D, Lathia J. Tumor cell-derived spermidine promotes a pro-tumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition. Journal of Clinical Investigation. 2025;135(2):10.1172/jci177824
Lim-Fat MJ, Bennett J, Ostrom Q, Touat M, Franceschi E, Schulte J, Bindra RS, Fangusaro J, Dhall G, Nicholson J, Jackson S, Davidson TB, Calaminus G, Robinson G, Whittle JR, Hau P, Ramaswamy V, Pajtler KW, Rudà R, Foreman NK, Hervey-Jumper SL, Das S, Dirks P, Bi WL, Huang A, Merchant TE, Fouladi M, Aldape K, Van den Bent MJ, Packer RJ, Miller JJ, Reardon DA, Chang SM, Haas-Kogan D, Tabori U, Hawkins C, Monje M, Wen PY, Bouffet E, Yeo KK. Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions. Neuro-Oncology. 2025;27(1):10.1093/neuonc/noae186
Schadewaldt V, O’Brien T, Kalla M, Krishnasamy M, Burns K, Bray SC, Gilbert C, De Abreu Lourenco R, Thomas J, Capurro D, Chapman W, Borda A, Dhillon RS, Whittle JR, Drummond KJ. Development of an evidence-informed implementation strategy for a digital supportive care platform for brain tumour patients, their carers and healthcare professionals. Digital Health. 2025;11:10.1177/20552076251316713
de la Fuente MI, Touat M, van den Bent MJ, Preusser M, Peters KB, Young RJ, Huang RY, Ellingson BM, Capper D, Phillips JJ, Halasz LM, Shih HA, Rudà R, Lim-Fat MJ, Blumenthal DT, Weller M, Arakawa Y, Whittle JR, Ducray F, Reardon DA, Bi WL, Minniti G, Rahman R, Hervey-Jumper S, Chang SM, Wen PY. The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma. Neuro-Oncology. 2024;:10.1093/neuonc/noae259
Hitchen N, Shahnam A, Manoharan S, Topp M, Mileshkin L, Lim AM, Whittle JR, Luen SJ, Solomon B, Lackovic K, Desai J, Tran B. Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012–2022. Asia-Pacific Journal of Clinical Oncology. 2024;20(6):10.1111/ajco.14100
